Johnson Matthey PLC (LON:JMAT - Get Free Report)'s stock price rose 29.4% during trading on Thursday . The stock traded as high as GBX 1,888 ($25.32) and last traded at GBX 1,797 ($24.10). Approximately 4,429,253 shares were traded during mid-day trading, an increase of 61% from the average daily volume of 2,754,108 shares. The stock had previously closed at GBX 1,389 ($18.63).
Johnson Matthey Price Performance
The company has a market capitalization of £3.02 billion, a price-to-earnings ratio of 30.69, a P/E/G ratio of 49,242.50 and a beta of 0.95. The firm has a 50-day simple moving average of GBX 1,294.86 and a two-hundred day simple moving average of GBX 1,372.17. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.00) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. As a group, analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.
Johnson Matthey Increases Dividend
The company also recently announced a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were paid a GBX 32 ($0.43) dividend. This is a boost from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. The ex-dividend date was Thursday, April 10th. Johnson Matthey's payout ratio is currently 130.84%.
Insider Activity at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon purchased 30 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, April 16th. The stock was bought at an average price of GBX 1,200 ($16.09) per share, with a total value of £360 ($482.77). 0.61% of the stock is owned by company insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
